Search Results - drug target




8 Results Sort By:
Inhibitors of the ubiquitin E3 ligase BCA2 as anti-cancer therapeutic agents
Background:Breast cancer associated protein 2 (BCA2) is a ubiquitin E3 ligase found in invasive breast cancer. Studies have shown that by decreasing its activity, breast cancer cell growth and invasiveness are diminished. Targeting this ligase and inhibiting its activity could play a role in treatment of breast cancer. A molecular approach to in...
Published: 8/3/2017   |   Inventor(s): Angelika Burger, Andrew Westwell
Keywords(s): Analog or Analogue, Breast Cancer, Cancer, Disease, Drug Target, Enzyme
Category(s): Diseases, Oncology, Therapeutics, Life Science, Research tools
Modified Ectodomain of Human EGFR as a Potential Anticancer Agent
Development of a protein that attenuates EGFR and/or EGFR family members and is comprised of a modified EGFR ectodomain. The protein inhibits signaling via the EGFR and/or EGFR family members. The protein includes a portion of the EGFR (or EGFR family member) and the "U" region epitope of EGFR related protein (ERRP), wherein the portion o...
Published: 8/3/2017   |   Inventor(s): Adhip Majumdar, Arun Rishi, Yingjie Yu
Keywords(s): Breast Cancer, Cancer, Cancer Therapies, Disease, Drug Target, Protein, Therapeutics
Category(s): Life Science, Biologicals, Diseases, Oncology
Dual action nanocarrier combining CXCR4 antagonist and polyplex gene delivery for treatment of metastatic cancer and other diseases
Novel bio-reducible polymer compositions which combine the ability to act as a CXCR4 antagonist and simultaneously provide enhanced gene delivery through the formation of inert nanocarrier polyplexes have been developed. As would be expected for biodegradable polymers, the cytotoxicity of these nanocarrier compositions are very low with measured IC...
Published: 9/10/2012   |   Inventor(s): David Oupicky, Jing Li
Keywords(s): Cancer, Cancer Therapies, Compound, Drug Delivery, Drug Target, Formulation, Imaging, Nanomaterials, Pharmaceuticals, Therapeutics
Category(s): Drug Delivery, Gene Therapy, Therapeutics, Life Science, Oncology, Nano-based, Metabolic disorders, Biologicals
GlyB4 Fusion with Neuregulin Heparin-Targeting Domain to Block Neuregulin Signaling
We have harnessed this natural targeting ability of NRG by fusing the HBD of NRG to soluble HER4. This fusion protein retains high affinity heparin binding to heparin and to cells that express heparan sulfates resulting in a more potent NRG antagonist. In vivo, it is targeted to peripheral nerve segments where it blocks the activity of NRG as a Sch...
Published: 5/16/2011   |   Inventor(s): Jeffrey Loeb, Qunfang Lee
Keywords(s): Anti-cancer, Biotechnology, Cancer risk, Cancer Therapies, Drug Delivery, Drug Target, Epilepsy
Category(s): Life Science, Drug Delivery, Other
Novel Mammalian Putative Phosphatidylinositol-4-Phosphate-5-Kinase
This invention is a novel mammalian gene involved in membrane trafficking, more specifically, insulin‑induced translocation of the fat/muscle-specific glucose transporter GLUT4. Background & Unmet Need: Both Type I (Juvenile onset) and Type II (Maturity onset) Diabetes Mellitus result in a profound state of high glucose in the circulatio...
Published: 5/18/2010   |   Inventor(s): Assia Shisheva
Keywords(s): DNA, Drug Target, Therapeutics
Category(s): Diseases, Life Science, Metabolic disorders, Therapeutics, Biologicals
DNA Molecule Encoding the B3 Adrenegic Receptor
This technology describes the correct protein sequence of the β3 receptor to aid in the development of adult-onset diabetes drugs. Background & Unmet Need: The β3 receptor is currently being developed as a therapeutic target for human obesity and adult onset diabetes mellitus by several pharmaceutical companies. In order to develop...
Published: 5/18/2010   |   Inventor(s): James Granneman, Kristine Lahners, Donald Rao
Keywords(s): Diabetes, Disease, DNA, Drug Target, Obesity, Therapeutics
Category(s): Life Science, Metabolic disorders, Diagnostics, Research tools, Receptors/targets
Antibodies to a Novel Cell Cycle and Apoptosis Regulatory Protein (CARP) -1
Wayne State University researchers have identified a novel cDNA which encodes a pro-apoptotic protein called CARP-1 (Cell Cycle and Apoptosis Regulatory Protein-1), which is expressed in many cancer cell types including breast and colon carcinoma cells. This novel cDNA can be used as a diagnostic and prognostic tool for many types of cancer. Bac...
Published: 5/7/2010   |   Inventor(s): Arun Rishi, Joseph Fontana
Keywords(s): Antibody, Breast Cancer, Cancer, Drug Target
Category(s): Diagnostic, Life Science, Research tools, Antibodies
Derivation of Molecular Targets of Cancer and Aging Using Cellular Immortalization-Specific Gene-Expression
This technology identifies molecular targets required for immortalization, which is a trait spontaneously acquired by cancer cells. These targets may provide a potential means to intervene in the process of aging or cancer development. Background & Unmet Need: Recent efforts to develop improved methods for breast cancer detection, staging, an...
Published: 5/7/2010   |   Inventor(s): Sorin Draghici, Olga Studitskaia, Michael Tainsky
Keywords(s): Cancer, Drug Target
Category(s): Diagnostic, Life Science, Oncology